Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will be attending Motilal Oswal Ideation Conference (MOSL) on June 8, 2022 physically. This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company's website www.supriyalifescience.com for your information and for the information of your members and the public at large. This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund. Request you to kindly take the same on record.
07-06-2022
Bigul

Supriya Lifescience Ltd - 543434 - Disclosure Of Related Party Transactions Pursuant To Regulation 23 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of Related Party Transactions for the half year ended March 31, 2022. Kindly take the same on your records.
01-06-2022
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings call held on Monday, May 23, 2022 at 3.30 P.M. IST to discuss operational and financial performance of the Company for the fourth quarter and year ended March 31, 2022. This is for your information and records.
27-05-2022
Bigul

Supriya Lifescience Ltd - 543434 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to Regulation 24A of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, we enclosed herewith Annual Secretarial Compliance Report dated May 27, 2022 issued by Mr. Mahesh Darji, Practicing Company Secretary, for the financial year ended March 31, 2022. Kindly take the information on record.
27-05-2022
Bigul

Supriya Lifescience Ltd - 543434 - Audio Recording Of Earnings Call

 In accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company''s Earnings Call held today (i.e., May 23, 2022) regarding discussion on operational and financial performance for the Fourth Quarter and Financial Year ended March 31, 2022 (Q4 and FY 2021-22) is available on the Company''s website. The recording can be accessed from the link given below: https://supriyalifescience.com/investor-relation/financial/earning-call-recordings/ Kindly take the information on record.
23-05-2022

Earnings Call for Q4FY22 of Supriya Lifescience

 Conference Call with Supriya Lifescience Manhttps://youtu.be/CvlNlXdt8Ksagement and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.
23-05-2022
Bigul

Supriya Lifescience Ltd - 543434 - Statement Of Deviation Or Variation In The Use Of Proceeds Of The Fresh Issue Of The Initial Public Offer Of The Company

 Pursuant to Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, please find enclosed herewith statement of deviation(s) or variation(s) in utilization of funds raised through Initial Public Offering (IPO) for the quarter ended March 31, 2022 in the prescribed format. Further, we hereby confirm that there is no deviation or variation in the utilisation of IPO proceeds from the objects stated in the prospectus dated December 21, 2021. Kindly take the same on record and acknowledge the receipt.
23-05-2022
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Investor Presentation

 This has a reference to our intimation letter dated May 21, 2022, wherein the Company has submitted Investor Presentation, inter-alia, to the Stock Exchanges. In connection herewith, please find enclosed herewith revised Investor presentation. You are requested to kindly take the same on record.
21-05-2022
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Investor Presentation. You are requested to kindly take the same on record.
21-05-2022
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 With reference to the above captioned subject, please find enclosed newspaper advertisement published in Financial Express (English) and Loksatta (Marathi) on Saturday, May 21, 2022, containing Audited Financial Results for the quarter and year ended March 31, 2022. You are requested to kindly take the same on record.
21-05-2022
Next Page
Close

Let's Open Free Demat Account